Heart size is tightly regulated across species (Heallen et al., 2011) . Some vertebrates such as fish and amphibians display robust, life-long capacity to reactivate proliferation of cardiomyocytes in response to injury, and the ability to completely regenerate their hearts without scar formation (Zhang et al., 2013) . In mammals, however, cardiomyocytes undergo cell-cycle withdrawal soon after birth, and the majority of postnatal cardiac growth has been attributed to cardiomyocytes growing in size, with little proliferation (Bergmann et al., 2009 ). In line with this observation, recent mouse studies revealed that mammals possess the capacity for complete cardiac regeneration immediately after birth (postnatal day 2 [P2]) but lose this ability precipitously by P7 (Porrello et al., 2011) . Now, in this issue of Cell, Ahmad Husain and colleagues (Naqvi et al., 2014 ) identify a new window of transient cardiomyocyte proliferation in preadolescent (P15) mouse hearts, which appears to be regulated through pathways known to modulate the early postnatal stages of heart development.
Using a combination of careful histomorphometry and dispersed cell counts, Naqvi et al. showed that cardiomyocyte size alone cannot account for the change in heart weight observed in the postnatal mouse heart (P10-P35), suggesting that an increase in cardiomyocyte number must also occur during this period. In support of this idea, they identified two time windows during which cardiomyocyte population number increased: the first occurs during P1-P4 with a 40% increase in cardiomyocyte number, and the second occurs between P14-P18 with a second 40% increase in cardiomyocyte cell number (Figure 1 ). Following the second burst and up to a year later, cardiomyocyte numbers remained the same. These findings set the stage for an exquisite line of experiments, showing that cardiomyocyte proliferation in the preadolescent heart occurs during a very tight time window. The authors found that the expression of cell-cycle genes is 5-to 12-fold higher by 9 a.m. on P15, reverting to previous levels by P16. Pulsechase experiments, measuring BrdU incorporation into S phase nuclei, also showed that cardiomyocytes start undergoing mitosis during the night of P14. Furthermore, transverse heart sections stained for aurora B, a kinase only expressed in M phase, revealed a 36-fold increase in cells undergoing mitosis between P14-P15, which dropped 5.8-fold by P16. Interestingly, and in contrast to the early postnatal heart (P2) which shows ubiquitous proliferation of cardiomyocytes, Naqvi et al. provided evidence for an unequal distribution of proliferating cardiomyocytes throughout the preadolescent heart. The vast majority of proliferation appeared to occur within the subendocardial (inner) zone of the left ventricle, with little proliferation in the subepicardial (outer) region of the left ventricle, the right ventricle, or atria. These findings are provocative because they suggest a more complex level of regulation, acting to specify a unique domain of cardiomyocyte responsiveness to proliferation signals. This regionalization of proliferation could be exploited in future studies to identify mechanisms regulating cardiomyocyte proliferation in the postmitotic heart based on common molecular/phenotypic signatures between the P2 heart and P15 subendocardium.
While investigating the mechanism leading to preadolescent cardiomyocyte mitosis, Naqvi et al. made a surprising finding pertaining to the challenge of initiating division in multinucleated cells such as cardiomyocytes. Mouse cardiomyocytes that undergo cell-cycle withdrawal typically experience a final round of DNA synthesis and nuclear division without cytokinesis, leading to bi-or multinucleation (Laflamme and Murry, 2011) . Naqvi et al. found a 2.3-fold increase in mononucleated cells in the afternoon of P15, coupled with a 60% decrease in binucleated cells, suggesting that binucleated cells give rise to mononucleated cells. They proposed a model according to which binuclear cells undergo karyokinesis of the two nuclei with cytokinesis taking place between the pair of nuclei. The end result of such division would be two mononuclear cells at the two poles and a smaller binucleated cardiomyocyte generated between them. Previous studies have shown that such 2+1 mitosis is feasible (Engel et al., 2005) , providing an interesting starting point to study mechanisms of activating cell proliferation in the multinucleated postmitotic adult heart.
Postnatal bursts in serum factors such as the thyroid hormone tri-iodothyronine (T3) and insulin-like growth factor 1 (IGF1) are responsible for some of the key structural and functional changes of the postnatal heart (Forhead and Fowden, 2014) . Based on this, Naqvi et al. measured serum T3 levels during the preadolescent stage and found a 5.6-fold increase between P10-P12. Propylthiouracil (PTU) treatment, which inhibits T3 biosynthesis, blocked the cardiac growth observed during the P14-P15 period. The lag between the T3 spike and the proliferative burst suggests an indirect mechanism, and in support of this notion, the authors suggested that T3 acts directly on the IGF1 signaling pathway to mediate these events. This is supported by the observation that Akt, a downstream component of IGF signaling, is found in nuclei only within the subendocardial region of the left ventricle on P15 and that PTU treatment abrogated IGF1-R/Akt pathway activity in P15 ventricles. Curiously, previous studies in late-term fetal sheep have indicated that T3 causes cardiomyocyte cell-cycle withdrawal (Chattergoon et al., 2012) and work from our laboratory has used T3 treatment as a modality for maturing hESC-derived cardiomyocytes with similar effects observed in the downregulation of cell proliferation (Yang et al., 2014) . There is a clear discrepancy between these findings, suggesting a context-dependent effect of T3 in modulating cardiomyocyte proliferation versus maturation, potentially through an IGF1R/Akt dependent process.
Lastly, Naqvi et al. tested the hypothesis that a transient window of cardiomyocyte proliferation may confer protection against acute myocardial injury by comparing response to myocardial infarction at different ages: in P2, P15, and P21 mice. Consistent with previous studies, Naqvi et al. observed that the P2 heart is capable of scarless cardiac regeneration postmyocardial infarction, correlating to increased cell-cycle activity in those hearts. In contrast, the P21 heart, which has no detectible cardiomyocyte cell-cycle activity, shows massive scarring and no regeneration. Based on a localized state of cardiomyocyte proliferation postinfarction, Naqvi et al. showed an intermediate potential for cardiac regeneration in the P15 heart. While this experiment provided some evidence for the protective effect of cardiomyocyte proliferation, testing the regenerative ability of a heart before the preadolescent burst (e.g., at P7), and showing that at P15 the heart can regenerate better than at P7, would have been more persuasive.
In summary, to our knowledge this study provides the first evidence that mature multinucleated cardiomyocytes can re-enter the cell cycle and The transition during heart development from proliferation to terminal differentiation has just gotten more complex. In the early postnatal period (P2 mouse panel), cardiomyocytes robustly proliferate and heart muscle has the ability to fully recover from injury. This regenerative capacity is lost by postnatal day 7 and is not retained in adulthood (P21 mouse panel). Naqvi et al. now show that cardiomyocyte proliferation is reactivated during a narrow time window in the preadolescent mouse heart (P15 mouse panel), delineating the cellular and molecular processes underlying this process. These findings provide new insights into the complex relationship between proliferation and regeneration in the postnatal heart. significantly contribute to cardiomyocyte proliferation. The mechanism and causal relationship between T3/IGF signaling and this proliferative burst remain unclear, and further studies will be needed to more specifically address these issues. Additional fate mapping studies that conditionally label postmitotic cardiomyocytes would help elucidate this phenomenon and determine the molecular mechanisms responsible for mediating this effect. Indeed, this study takes a step forward in identifying ways to stimulate proliferation in postmitotic cardiomyocytes and may yield valuable insights into therapeutic treatments for inherited and acquired heart diseases.
The anaphase-promoting complex/cyclosome targets proteins for degradation by catalyzing homotypic ubiquitin chains of different linkage types. In this issue of Cell, Meyer and Rape diversify the degradation signals by demonstrating that the APC/C and its cognate E2 conjugating enzymes enhance the rate of substrate degradation by decorating them with branched Lys11 and Lys48 ubiquitin chains.
Ubiquitylation is the most versatile posttranslational modification known to date and is involved in the regulation of numerous cellular processes (Grabbe et al., 2011) . Ubiquitin (Ub) is predominantly attached to lysine residues of other proteins by a tightly regulated multistep enzymatic process involving activation by E1 enzymes, conjugation by E2 enzymes, and, finally, ligation by E3 ligases. Attachment of Ub may result in monoubiquitylated proteins or modification with Ub chains composed of several Ub moieties. In the latter case, the internal seven lysines or the aminoterminal methionine 1 of Ub are modified in successive rounds of conjugation. Given these multiple linkage sites, the pool of theoretically viable Ub chains with different structures is almost unlimited, underscoring the versatility of the system. However, so far, only a limited number of defined Ub structures were identified in vivo, and research has mainly concentrated on chains of homogenously linked Ub. In this issue of Cell, Meyer and Rape (2014) define a physiological role for branched Ub chains in cell-cycle regulation. This may mark the entry into a new era of Ub research and definitely adds a new twist to the deciphering of the Ub code, as well as to the understanding of the enzymatic machinery involved.
In eukaryotes, destruction of cellcycle regulators is essential for progression through and exit out of mitosis. The anaphase-promoting complex/cyclosome (APC/C) is a large, multisubunit E3 ligase that targets key cell-cycle regulators for ubiquitylation and subsequent degradation by the 26S proteasome (Peters, 2006) . The first Ub chains described to relate such signals were Lys48 linked Ub chains, but how the APC/C functioned to catalyze these chain types remained unknown. Mechanistic details emerged from studies in
